< Terug naar vorige pagina
Onderzoeker
Erik De Clercq
- Disciplines:Microbiologie, Systeembiologie, Laboratoriumgeneeskunde
Affiliaties
- Laboratorium Virologie en Chemotherapie (Rega Instituut) (Afdeling)
Lid
Vanaf1 okt 1999 → 30 sep 2013
Publicaties
11 - 20 van 562
- Design, synthesis, and mechanistic study of 2-piperazineone-bearing peptidomimetics as novel HIV capsid modulators(2023)
Auteurs: Erik De Clercq, Christophe Pannecouque
Pagina's: 1272 - 1295 - Picomolar inhibitor of reverse transcriptase featuring significantly improved metabolic stability(2023)
Auteurs: Christophe Pannecouque, Erik De Clercq
Pagina's: 3054 - 3066 - Discovery of novel sulfonamide substituted indolylarylsulfones as potent HIV-1 inhibitors with better safety profiles(2023)
Auteurs: Erik De Clercq, Christophe Pannecouque
Pagina's: 2747 - 2764 - Therapeutic strategies for COVID-19: progress and lessons learned(2023)
Auteurs: Erik De Clercq
Pagina's: 449 - 475 - Escaping from Flatland: Multiparameter Optimization Leads to the Discovery of Novel Tetrahydropyrido[4,3-d]pyrimidine Derivatives as Human Immunodeficiency Virus-1 Non-nucleoside Reverse Transcriptase Inhibitors with Superior Antiviral Activities against Non-nucleoside Reverse Transcriptase Inhibitor-Resistant Variants and Favorable Drug-like Profiles(2023)
Auteurs: Erik De Clercq, Christophe Pannecouque
Pagina's: 8643 - 8665 - Hydrogen Bonding (Base Pairing) in Antiviral Activity(2023)
Auteurs: Erik De Clercq
- Discovery of diarylpyrimidine derivatives bearing piperazine sulfonyl as potent HIV-1 nonnucleoside reverse transcriptase inhibitors(2023)
Auteurs: Erik De Clercq, Christophe Pannecouque
- Fragment Hopping-Based Design of Novel Biphenyl-DAPY Derivatives as Potent Non-Nucleoside Reverse Transcriptase Inhibitors Featuring Significantly Improved Anti-Resistance Efficacy(2023)
Auteurs: Christophe Pannecouque, Erik De Clercq
Pagina's: 4755 - 4767 - Linker optimization of HEPT derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors: From S =O to CHOR(2023)
Auteurs: Christophe Pannecouque, Erik De Clercq
- Structure-directed linker optimization of novel HEPTs as non-nucleoside inhibitors of HIV-1 reverse transcriptase(2023)
Auteurs: Christophe Pannecouque, Erik De Clercq
Patenten
1 - 7 van 7
- Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production (Inventor)
- 6-[2-(PHOSPHONOMETHOXY)ALKOXY] PYRIMIDINE DERIVATIVES HAVING ANTIVIRAL ACTIVITY (Inventor)
- Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production (Inventor)
- Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production (Inventor)
- VIRAL INHIBITORS (Inventor)
- VIRAL INHIBITORS (Inventor)
- PHOSPHONATE NUCLEOSIDES USEFUL AS ACTIVE INGREDIENTS IN PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS, AND INTERMEDIATES FOR THEIR PRODUCTION (Inventor)